Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) with double expression of c-MYC and BCL2 protein is associated with dismal outcome after treatment with R-CHOP. Local data on disease burden and survival outcome in DLBCL is limited. We investigated the prognostic values of c-MYC/BCL2 protein co-expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Teoh, Ching Soon, Lee, Soo Yin, Chiang, Su Kien, Chew, Teng Keat, Goh, Ai Sim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031813/
https://www.ncbi.nlm.nih.gov/pubmed/29801406
http://dx.doi.org/10.22034/APJCP.2018.19.5.1229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031813/
https://www.ncbi.nlm.nih.gov/pubmed/29801406
http://dx.doi.org/10.22034/APJCP.2018.19.5.1229

Ejemplares similares